Published in Am J Hypertens on January 18, 2013
Development of hypertension in overweight adolescents: a review. Adolesc Health Med Ther (2015) 0.88
Retinal vascular imaging in early life: insights into processes and risk of cardiovascular disease. J Physiol (2015) 0.80
Subclinical Indication of Linkage Between Markers of Skeletal and Cardiovascular Properties. Bone Res (2013) 0.75
Effects of donor pretreatment with dopamine on graft function after kidney transplantation: a randomized controlled trial. JAMA (2009) 3.83
Progression of aortic pulse wave velocity in patients with chronic kidney disease. J Clin Hypertens (Greenwich) (2013) 2.06
Circulating adipocyte fatty acid-binding protein levels and cardiovascular morbidity and mortality in patients with coronary heart disease: a 10-year prospective study. Arterioscler Thromb Vasc Biol (2012) 1.80
Association of ambulatory arterial stiffness index and brachial pulse pressure is restricted to dippers. J Hypertens (2008) 1.77
Prophylaxis of contrast material-induced nephropathy in patients in intensive care: acetylcysteine, theophylline, or both? A randomized study. Radiology (2006) 1.68
Aortic pulse wave velocity predicts mortality in chronic kidney disease stages 2-4. J Hypertens (2014) 1.68
The A20 gene protects kidneys from ischaemia/reperfusion injury by suppressing pro-inflammatory activation. J Mol Med (Berl) (2008) 1.58
Candesartan improves blood pressure control and reduces proteinuria in renal transplant recipients: results from SECRET. Nephrol Dial Transplant (2009) 1.58
Molecular basis for the inhibition of p53 by Mdmx. Cell Cycle (2007) 1.55
Imatinib attenuates end-organ damage in hypertensive homozygous TGR(mRen2)27 rats. Hypertension (2006) 1.53
Assessment of systolic aortic pressure and its association to all cause mortality critically depends on waveform calibration. J Hypertens (2015) 1.51
Relapsing polychondritis: An autoimmune disease with many faces. Autoimmun Rev (2010) 1.47
Direct renin inhibition in a rat model of chronic allograft injury. Transplantation (2011) 1.42
Sexual dimorphism in renal ischemia-reperfusion injury in rats: possible role of endothelin. Kidney Int (2002) 1.41
Aortic to brachial pulse pressure amplification as functional marker and predictor of renal function loss in chronic kidney disease. J Clin Hypertens (Greenwich) (2014) 1.41
Automated Greulich-Pyle bone age determination in children with chronic kidney disease. Pediatr Nephrol (2015) 1.39
Comment on "Tricuspid annular plane systolic excursion and right ventricular ejection fraction in pediatric and adolescent patients with tetralogy of Fallot, patients with atrial septal defect, and age-matched normal subjects". Clin Res Cardiol (2011) 1.38
Behavioral conditioning of immunosuppression is possible in humans. FASEB J (2002) 1.29
Citrate pharmacokinetics and calcium levels during high-flux dialysis with regional citrate anticoagulation. Nephrol Dial Transplant (2009) 1.27
Isoquinolin-1-one inhibitors of the MDM2-p53 interaction. ChemMedChem (2008) 1.27
Long-term follow-up after rituximab for steroid-dependent idiopathic nephrotic syndrome. Nephrol Dial Transplant (2011) 1.24
Suppressed T-cell activation by IFN-gamma-induced expression of PD-L1 on renal tubular epithelial cells. Nephrol Dial Transplant (2004) 1.22
Association of hypertension with symptoms of benign prostatic hyperplasia. J Urol (2004) 1.21
Two corticosteroid-free regimens-tacrolimus monotherapy after basiliximab administration and tacrolimus/mycophenolate mofetil-in comparison with a standard triple regimen in renal transplantation: results of the Atlas study. Transplantation (2005) 1.17
Relation between plasma fibroblast growth factor-23, serum fetuin-A levels and coronary artery calcification evaluated by multislice computed tomography in patients with normal kidney function. Clin Endocrinol (Oxf) (2007) 1.16
Expression of Foxp3 in colorectal cancer but not in Treg cells correlates with disease progression in patients with colorectal cancer. PLoS One (2013) 1.13
The IKK-2/Ikappa Balpha /NF-kappa B pathway plays a key role in the regulation of CCR3 and eotaxin-1 in fibroblasts. A critical link to dermatitis in Ikappa Balpha -deficient mice. J Biol Chem (2001) 1.11
Recipient Toll-like receptors contribute to chronic graft dysfunction by both MyD88- and TRIF-dependent signaling. Dis Model Mech (2009) 1.11
Golgi-to-phagosome transport of acid sphingomyelinase and prosaposin is mediated by sortilin. J Cell Sci (2010) 1.10
Hypertension augments cardiac Toll-like receptor 4 expression and activity. Hypertens Res (2011) 1.08
Intima-media thickness in children--need for more parameters? Hypertension (2014) 1.06
Randomized, double-blind, placebo-controlled trial of oral sirolimus for restenosis prevention in patients with in-stent restenosis: the Oral Sirolimus to Inhibit Recurrent In-stent Stenosis (OSIRIS) trial. Circulation (2004) 1.06
Anti-glomerular basement membrane antibody disease: a rare autoimmune disorder affecting the kidney and the lung. Autoimmun Rev (2012) 1.04
Multi-modal treatment of calciphylaxis with sodium-thiosulfate, cinacalcet and sevelamer including long-term data. Kidney Blood Press Res (2013) 1.04
Association between carotid diameter and the advanced glycation end product N-epsilon-carboxymethyllysine (CML). Cardiovasc Diabetol (2009) 1.02
Tumours after kidney transplantation. Curr Opin Urol (2003) 1.02
High calorie diet triggers hypothalamic angiopathy. Mol Metab (2012) 1.01
The effect of ischemia/reperfusion on the kidney graft. Curr Opin Organ Transplant (2014) 1.00
Administration of interleukin-1 receptor antagonist ameliorates renal ischemia-reperfusion injury. Transpl Int (2008) 0.99
Partial anomalous pulmonary vein connection: an underestimated cardiovascular defect in Ullrich-Turner syndrome. Eur J Pediatr (2004) 0.98
Effect of a triple blockade of the renin-angiotensin-system in recurrent focal segmental glomerulosclerosis after kidney transplantation. Transpl Int (2009) 0.97
Anti-inflammatory treatment strategies for ischemia/reperfusion injury in transplantation. J Inflamm (Lond) (2010) 0.97
Early application of Met-RANTES ameliorates chronic allograft nephropathy. Kidney Int (2002) 0.97
Images in clinical medicine: Subconjunctival Dirofilaria repens. N Engl J Med (2010) 0.96
Carbamazepine for prevention of oxaliplatin-related neurotoxicity in patients with advanced colorectal cancer: final results of a randomised, controlled, multicenter phase II study. Invest New Drugs (2006) 0.96
Pharmacokinetics and protein adduct formation of the pharmacologically active acyl glucuronide metabolite of mycophenolic acid in pediatric renal transplant recipients. Ther Drug Monit (2002) 0.95
STAT1-mediated signal integration between IFNγ and LPS leads to increased EC and SMC activation and monocyte adhesion. Am J Physiol Cell Physiol (2011) 0.95
Relation of increased short-term variability of QT interval to congenital long-QT syndrome. Am J Cardiol (2009) 0.95
Molecular staging in stage II and III melanoma patients and its effect on long-term survival. J Clin Oncol (2005) 0.94
Toll-like receptor (TLR) 7 and TLR8 expression on CD133+ cells in colorectal cancer points to a specific role for inflammation-induced TLRs in tumourigenesis and tumour progression. Eur J Cancer (2010) 0.93
In vitro and in vivo synergy of MCP compounds with mitogen-activated protein kinase pathway- and microtubule-targeting inhibitors. Mol Cancer Ther (2007) 0.92
Donor antigen-specific regulatory T-cell function affects outcome in kidney transplant recipients. Kidney Int (2011) 0.92
Toll-like receptors 2 and 4 in renal ischemia/reperfusion injury. Pediatr Nephrol (2010) 0.92
Effect of short-term high-protein compared with normal-protein diets on renal hemodynamics and associated variables in healthy young men. Am J Clin Nutr (2009) 0.92
KMnO(4)-Mediated oxidation as a continuous flow process. Org Lett (2010) 0.92
Urinary adiponectin excretion: a novel marker for vascular damage in type 2 diabetes. Diabetes (2009) 0.91
Mdm2 and MdmX inhibitors for the treatment of cancer: a patent review (2011-present). Expert Opin Ther Pat (2013) 0.91
Aspects of quality of life through end-stage renal disease. Qual Life Res (2003) 0.90
Damage-associated molecular pattern activated Toll-like receptor 4 signalling modulates blood pressure in L-NAME-induced hypertension. Cardiovasc Res (2013) 0.90
Dynamic retinal vessel response to flicker in obesity: A methodological approach. Microvasc Res (2010) 0.89
[Quality of life in patients before and after kidney transplantation]. Psychother Psychosom Med Psychol (2002) 0.89
Safety of telmisartan in patients with arterial hypertension : an open-label observational study. Drug Saf (2004) 0.89
Inhibition of matrix metalloproteinases during chronic allograft nephropathy in rats. Transplantation (2005) 0.88
Renoprotective effect of erythropoietin in rats subjected to ischemia/reperfusion injury: gender differences. Surgery (2011) 0.88
Associations of fetuin-A levels with vascular disease in type 2 diabetes patients with early diabetic nephropathy. Cardiovasc Diabetol (2010) 0.88
Mycophenolate mofetil versus cyclosporin A in children with frequently relapsing nephrotic syndrome. J Am Soc Nephrol (2013) 0.87
Fumaric acid esters are potent immunosuppressants: inhibition of acute and chronic rejection in rat kidney transplantation models by methyl hydrogen fumarate. Arch Dermatol Res (2002) 0.86
C-terminal agrin fragment--a new fast biomarker for kidney function in renal transplant recipients. Am J Nephrol (2013) 0.85
Effect of Renin-Angiotensin system blockade on insulin resistance and inflammatory parameters in patients with impaired glucose tolerance. Diabetes Care (2010) 0.85
MEIS1 and BTBD9: genetic association with restless leg syndrome in end stage renal disease. J Med Genet (2011) 0.85
N epsilon-(carboxymethyl)lysine during the early development of hypertension. Ann N Y Acad Sci (2007) 0.84
Tumour-mediated TRAIL-Receptor expression indicates effective apoptotic depletion of infiltrating CD8+ immune cells in clinical colorectal cancer. Eur J Cancer (2010) 0.84
STAT1 as a central mediator of IFNγ and TLR4 signal integration in vascular dysfunction. JAKSTAT (2012) 0.84
Serum fetuin-A, cardiovascular risk factors, and six-year follow-up outcome in patients with coronary heart disease. Am J Cardiol (2010) 0.84
Diagnostic utility of Acoustic Radiation Force Impulse (ARFI) imaging in primary Sjoegren`s syndrome. Eur Radiol (2015) 0.83
Kidney function and clinical recommendations of drug dose adjustment in geriatric patients. BMC Geriatr (2013) 0.83
C-terminal agrin fragment (CAF) as a serum biomarker for residual renal function in peritoneal dialysis patients. Int Urol Nephrol (2014) 0.83
Myeloid-related protein 8/14 complex describes microcirculatory alterations in patients with type 2 diabetes and nephropathy. Cardiovasc Diabetol (2009) 0.83
Quality of life in kidney recipients: comparison of tacrolimus and cyclosporine-microemulsion. Clin Transplant (2002) 0.83
Microvascular dysfunction in the course of metabolic syndrome induced by high-fat diet. Cardiovasc Diabetol (2014) 0.83